Evidence map›Paper›PMID 31395002›Full record

ArticlePalliative medicine2019

Delirium in the palliative care setting: "Sorting" out the confusion.

David Hui

Registry-linked trialAbstract readEditorialComment
PubMed Publisher
In one paragraph

Article in Palliative medicine, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04833023 (HALO Trial), which is not on this map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04833023 phase3unknown statusnot on this mapstarted 2022, after this paper: background citation

HALO Trial: Haloperidol vs Olanzapine in Hyperactive Delirium in Palliative Care Patients; A Multi-Centre, Randomised-Controlled Trial

TypeinterventionalSponsorTan Tock Seng HospitalRan2022 to 2024Enrolled72ConditionsHaloperidol, Advanced Cancer, Hyperactive Delirium, OlanzapineArmsHaldol 2mg/ml oral solution, Olanzapine Actavis 5mg orodispersible tablet
3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Prevalence of Delirium in End-of-Life Palliative Care Patients: An Observational Study.Medical principles and practice : international journal of the Kuwait University, Health Science Centre · 2022
    Observational
  2. Review
  3. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

1 author.

David HuiDepartment of Palliative Care, Rehabilitation & Integrative Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

Funding

Strategies for Persistent Agitated Delirium in Palliative CareR01CA225701 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI HUI, DAVID · 2019 to 2022
$1.9M
A Randomized Controlled Trial of Dexamethasone for Dyspnea in Cancer PatientsR01CA214960 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI HUI, DAVID · 2017 to 2020
$1.6M
Palliative Therapies for Refractory Delirium in Advanced CancerR21NR016736 · NINR · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI HUI, DAVID · 2017 to 2018
$455k
NCI NIH HHS R01 CA225701NINR NIH HHS R21 NR016736
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

DeliriumHospice and Palliative Care NursingHumansIncidencePalliative CarePrevalence

Identifiers

PMID31395002

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.